vimarsana.com

PARIS--(BUSINESS WIRE)--Regulatory News:The Combined General Meeting of shareholders of Advicenne (Euronext Growth Paris ALDVI - FR0013296746), a specialty pharmaceutical company dedicated to the development and commercialization of innovative treatments for those suffering from rare renal diseases, met on June 8, 2...

Related Keywords

France ,Paris ,France General ,Canada ,French ,Advicenne Euronext ,Didier Laurens , ,Regulatory News ,Combined General Meeting ,Euronext Growth Paris ,Faubourg Saint Honor ,General Meeting ,Philippe Boucheron ,Marketing Approval ,Euronext Paris ,Registration Document ,

© 2024 Vimarsana

vimarsana.com © 2020. All Rights Reserved.